-
EP4291232
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4291232
| EP4291232 - ANTIBODIES THAT BIND METAPNEUMOVIRUS, ANTIGENIC METAPNEUMOVIRUS PROTEINS, AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 17.11.2023 Database last updated on 22.08.2024 | |
| Former | The international publication has been made Status updated on 19.08.2022 | Most recent event Tooltip | 19.04.2024 | Change: Validation states | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states Merck Sharp & Dohme LLC 126 East Lincoln Avenue Rahway, New Jersey 07065 / US | [2023/51] | Inventor(s) | 01 /
CHEN, Zhifeng West Point, Pennsylvania 19486 / US | 02 /
COX, Kara, S. North Wales, Pennsylvania 19454-2505 / US | 03 /
FRIDMAN, Arthur Rahway, New Jersey 07065-0907 / US | 04 /
GALLI, Jennifer Dawn West Point, Pennsylvania 19486 / US | 05 /
SU, Hua-Poo West Point, Pennsylvania 19486 / US | 06 /
TANG, Aimin West Point, Pennsylvania 19486 / US | 07 /
VORA, Kalpit West Point, Pennsylvania 19486 / US | 08 /
WEN, Zhiyun West Point, Pennsylvania 19486 / US | 09 /
XIAO, Xiao Boston, Massachusetts 02115-5727 / US | 10 /
ZHANG, Lan West Point, Pennsylvania 19486 / US | [2023/51] | Representative(s) | Merck Sharp & Dohme LLC 120 Moorgate London EC2M 6UR / GB | [2023/51] | Application number, filing date | 22753192.8 | 08.02.2022 | [2023/51] | WO2022US15565 | Priority number, date | US202163148920P | 12.02.2021 Original published format: US 202163148920 P | US202163276172P | 05.11.2021 Original published format: US 202163276172 P | [2023/51] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2022173714 | Date: | 18.08.2022 | Language: | EN | [2022/33] | Type: | A2 Application without search report | No.: | EP4291232 | Date: | 20.12.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 18.08.2022 takes the place of the publication of the European patent application. | [2023/51] | Search report(s) | International search report - published on: | US | 10.11.2022 | Classification | IPC: | A61K39/395 | [2023/51] | CPC: |
C07K16/1027 (EP,KR);
A61K39/155 (KR);
A61P31/14 (KR);
C07K14/005 (KR);
A61K2039/505 (KR);
C07K2317/34 (EP,KR);
C07K2317/55 (EP,KR);
C07K2317/56 (EP,KR);
C07K2317/565 (EP,KR);
C07K2317/92 (EP,KR);
C07K2317/94 (EP,KR);
C12N2760/18322 (KR);
C12N2760/18334 (KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/51] | Extension states | BA | 12.09.2023 | ME | 12.09.2023 | Validation states | MA | 12.09.2023 | MD | 12.09.2023 | TN | 12.09.2023 | Title | German: | ANTIKÖRPER ZUR BINDUNG VON METAPNEUMOVIRUS, ANTIGENE METAPNEUMOVIRUSPROTEINE UND VERWENDUNGEN DAVON | [2023/51] | English: | ANTIBODIES THAT BIND METAPNEUMOVIRUS, ANTIGENIC METAPNEUMOVIRUS PROTEINS, AND USES THEREOF | [2023/51] | French: | ANTICORPS SE LIANT AU MÉTAPNEUMOVIRUS, PROTÉINES DE MÉTAPNEUMOVIRUS ANTIGÉNIQUES ET LEURS UTILISATIONS | [2023/51] | Entry into regional phase | 12.09.2023 | National basic fee paid | 12.09.2023 | Search fee paid | 12.09.2023 | Designation fee(s) paid | 12.09.2023 | Examination fee paid | Examination procedure | 12.09.2023 | Examination requested [2023/51] | 22.03.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 13.02.2024 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2004045512 (GENMAB AS [DK], et al); | [A]WO2008108918 (UNIV MASSACHUSETTS [US], et al); | [A]WO2010149743 (ID BIOMEDICAL CORP QUEBEC [CA], et al); | [AAA]US2011135645 (WILLIAMSON R ANTHONY [US], et al); | [A]WO2014204280 (HANALL BIOPHARMA CO LTD [KR]); | [A]WO2020223392 (TOTIENT INC [US]) |